PMC:7565665 / 68143-69313
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T438 | 218-225 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T439 | 242-257 | Body_part | denotes | plasma membrane | http://purl.org/sig/ont/fma/fma63841 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T489 | 725-727 | Disease | denotes | CF | http://purl.obolibrary.org/obo/MONDO_0009061 |
T490 | 863-876 | Disease | denotes | infections in | http://purl.obolibrary.org/obo/MONDO_0005550 |
T491 | 877-879 | Disease | denotes | CF | http://purl.obolibrary.org/obo/MONDO_0009061 |
T492 | 888-890 | Disease | denotes | CF | http://purl.obolibrary.org/obo/MONDO_0009061 |
T493 | 1007-1027 | Disease | denotes | respiratory diseases | http://purl.obolibrary.org/obo/MONDO_0005087 |
T494 | 1148-1158 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T789 | 180-184 | http://purl.obolibrary.org/obo/PR_000001044 | denotes | CFTR |
T790 | 242-248 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T791 | 249-257 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T792 | 336-340 | http://purl.obolibrary.org/obo/PR_000001044 | denotes | CFTR |
T793 | 432-436 | http://purl.obolibrary.org/obo/PR_000001044 | denotes | CFTR |
T794 | 476-480 | http://purl.obolibrary.org/obo/PR_000001044 | denotes | CFTR |
T795 | 644-645 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T796 | 830-833 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T797 | 1049-1053 | http://purl.obolibrary.org/obo/PR_000001044 | denotes | CFTR |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T85472 | 18-28 | Chemical | denotes | cysteamine | http://purl.obolibrary.org/obo/CHEBI_17141|http://purl.obolibrary.org/obo/CHEBI_58029 |
T158 | 115-125 | Chemical | denotes | cysteamine | http://purl.obolibrary.org/obo/CHEBI_17141|http://purl.obolibrary.org/obo/CHEBI_58029 |
T55491 | 218-225 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T7519 | 348-358 | Chemical | denotes | cysteamine | http://purl.obolibrary.org/obo/CHEBI_17141|http://purl.obolibrary.org/obo/CHEBI_58029 |
T44863 | 608-618 | Chemical | denotes | cysteamine | http://purl.obolibrary.org/obo/CHEBI_17141|http://purl.obolibrary.org/obo/CHEBI_58029 |
T28868 | 742-751 | Chemical | denotes | dendrimer | http://purl.obolibrary.org/obo/CHEBI_51338|http://purl.obolibrary.org/obo/CHEBI_61483 |
T31667 | 1103-1114 | Chemical | denotes | antibiotics | http://purl.obolibrary.org/obo/CHEBI_33281 |
T19153 | 1143-1146 | Chemical | denotes | MDR | http://purl.obolibrary.org/obo/CHEBI_53218 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1699 | 180-184 | Gene | denotes | CFTR | Gene:1080 |
1700 | 336-340 | Gene | denotes | CFTR | Gene:1080 |
1701 | 432-436 | Gene | denotes | CFTR | Gene:1080 |
1702 | 476-480 | Gene | denotes | CFTR | Gene:1080 |
1703 | 561-574 | Species | denotes | P. aeruginosa | Tax:287 |
1704 | 806-819 | Species | denotes | P. aeruginosa | Tax:287 |
1705 | 891-899 | Species | denotes | patients | Tax:9606 |
1706 | 18-28 | Chemical | denotes | cysteamine | MESH:D003543 |
1707 | 115-125 | Chemical | denotes | cysteamine | MESH:D003543 |
1708 | 608-618 | Chemical | denotes | cysteamine | MESH:D003543 |
1709 | 729-739 | Chemical | denotes | Cysteamine | MESH:D003543 |
1710 | 863-873 | Disease | denotes | infections | MESH:D007239 |
1711 | 1007-1027 | Disease | denotes | respiratory diseases | MESH:D012140 |
1712 | 1049-1065 | Disease | denotes | CFTR dysfunction | MESH:D009461 |
1713 | 1148-1158 | Disease | denotes | infections | MESH:D007239 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T904 | 180-184 | http://purl.obolibrary.org/obo/GO_0005260 | denotes | CFTR |
T905 | 336-340 | http://purl.obolibrary.org/obo/GO_0005260 | denotes | CFTR |
T906 | 385-394 | http://purl.obolibrary.org/obo/GO_0016236 | denotes | autophagy |
T907 | 385-394 | http://purl.obolibrary.org/obo/GO_0006914 | denotes | autophagy |
T908 | 432-436 | http://purl.obolibrary.org/obo/GO_0005260 | denotes | CFTR |
T909 | 476-480 | http://purl.obolibrary.org/obo/GO_0005260 | denotes | CFTR |
T910 | 481-490 | http://purl.obolibrary.org/obo/GO_0016236 | denotes | autophagy |
T911 | 481-490 | http://purl.obolibrary.org/obo/GO_0006914 | denotes | autophagy |
T912 | 1049-1053 | http://purl.obolibrary.org/obo/GO_0005260 | denotes | CFTR |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T355 | 0-70 | Sentence | denotes | Studies exploring cysteamine-dendrimers have revealed similar results. |
T356 | 71-278 | Sentence | denotes | Two of our recent studies demonstrated that cysteamine-based dendrimers were able to not only decrease ΔF508-CFTR aggregation, but also rescue the protein to increase the plasma membrane expression [45,149]. |
T357 | 279-455 | Sentence | denotes | Moreover, these investigations showed that this recue of CFTR by the cysteamine-dendrimers alleviated the autophagy impairment associated with the ΔF508-CFTR mutation [45,149]. |
T358 | 456-600 | Sentence | denotes | This alleviation of CFTR-autophagy impairment was further shown to increase the clearance and killing of P. aeruginosa in both studies [45,149]. |
T359 | 601-728 | Sentence | denotes | Hence, cysteamine-based dendrimers provide a therapeutic option in the treatment of both acute and chronic exacerbations in CF. |
T360 | 729-931 | Sentence | denotes | Cysteamine’s dendrimer-based formulation also proved beneficial for clearing P. aeruginosa, and thus has potential for treating other infections in CF and non-CF patients who are prone to exacerbations. |
T361 | 932-1170 | Sentence | denotes | The added advantage of this intervention strategy is that exacerbations in respiratory diseases including those with CFTR dysfunction may be treated and prevented without antibiotics, where multidrug-resistant (MDR) infections are common. |